74-55-5
74-55-5 structure
- Name: Ethambutol
- Chemical Name: ethambutol
- CAS Number: 74-55-5
- Molecular Formula: C10H24N2O2
- Molecular Weight: 204.310
- Catalog: API Synthetic anti-infective drugs Anti-tuberculosis leprosy
- Create Date: 2018-07-05 13:14:30
- Modify Date: 2024-01-02 19:48:10
-
Ethambutol is a bacteriostatic antimycobacterial agent, which obstructs the formation of cell wall by inhibiting arabinosyl transferases.Target: AntibacterialEthambutol directly affects two polymers, arabinogalactan (AG) and lipoarabinomannan (LAM) in Mycobacterium smegmatis. In M. smegmatis, Ethambutol inhibits synthesis of arabinan completely and inhibits AG synthesis most likely as a consequence of this; more than 50% of the cell arabinan is released from the bacteria following Ethambutol treatment, whereas no galactan is released. Ethambutol main targets against embB gene product in M. avium. Ethambutol induces 60% changes in the embB gene in M. tuberculosis resistant mutants [1]. Ethambutol is effective against actively growing microorganisms of the genus Mycobacterium, including M. tuberculosis. Nearly all strains of M. tuberculosis and M. kansasii as well as a number of strains of the M. aviumcomplex (MAC) are sensitive to Ethambutol. [1] Ethambutol is potency against M. tuberculosis (H37Rv) with MIC of 0.5 μg/mL in vitro [2]. Ethambutol is efficient on treatment of mycobacterial-infected macrophages. When M. tuberculosis infected macrophages are treated with 6 μg/mL Ethambutol, the log CFUs following treatment for 3 days is 4.17, while value in control group is 4.8. The MICs for M. avium (MTCC 1723) and M. smegmatis (MTCC 6) are 15 μg/mL and 0.18 μg/mL, respectively. Ethambutol is efficient in animal model. 100 mg/kg Ethambutol given orally 15 days post i.v. infection 1 ×/week for 5 weeks, induces a lower log CFU compared with untreatment (4.59 vs 5.07) [3].
| Name | ethambutol |
|---|---|
| Synonyms |
(S,S)-Et,Et-FerroTANE
(+)-1,1'-BIS[(2R,4R)-2,4-DIETHYLPHOSPHONATO]FERROCENE R,R-Et-FerroTANE (S,S)-2,2'-(ethylenediimino)di-1-butanol (R,R)-ET-FERROTANE(TM) (+)-1,1'-BIS((2R,4R)-2,4-DIETHYLPHOSPHOTANO)FERROCENE (S,S)-1-[1-(DI-TERT-BUTYLPHOSPHINO)ETHYL]-2-(DIPHENYLPHOSPHINO)FERROCENE Et-Ferrotane 1-Butanol, 2,2'-(1,2-ethanediyldiimino)bis- Ethambutol (S)-(+)-1-[(R)-2-(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLDI-T-BUTYLPHOSPHINE 2,2'-(1,2-Ethanediyldiimino)di(1-butanol) JOSIPHOS SL-J002-2 |
| Description | Ethambutol is a bacteriostatic antimycobacterial agent, which obstructs the formation of cell wall by inhibiting arabinosyl transferases.Target: AntibacterialEthambutol directly affects two polymers, arabinogalactan (AG) and lipoarabinomannan (LAM) in Mycobacterium smegmatis. In M. smegmatis, Ethambutol inhibits synthesis of arabinan completely and inhibits AG synthesis most likely as a consequence of this; more than 50% of the cell arabinan is released from the bacteria following Ethambutol treatment, whereas no galactan is released. Ethambutol main targets against embB gene product in M. avium. Ethambutol induces 60% changes in the embB gene in M. tuberculosis resistant mutants [1]. Ethambutol is effective against actively growing microorganisms of the genus Mycobacterium, including M. tuberculosis. Nearly all strains of M. tuberculosis and M. kansasii as well as a number of strains of the M. aviumcomplex (MAC) are sensitive to Ethambutol. [1] Ethambutol is potency against M. tuberculosis (H37Rv) with MIC of 0.5 μg/mL in vitro [2]. Ethambutol is efficient on treatment of mycobacterial-infected macrophages. When M. tuberculosis infected macrophages are treated with 6 μg/mL Ethambutol, the log CFUs following treatment for 3 days is 4.17, while value in control group is 4.8. The MICs for M. avium (MTCC 1723) and M. smegmatis (MTCC 6) are 15 μg/mL and 0.18 μg/mL, respectively. Ethambutol is efficient in animal model. 100 mg/kg Ethambutol given orally 15 days post i.v. infection 1 ×/week for 5 weeks, induces a lower log CFU compared with untreatment (4.59 vs 5.07) [3]. |
|---|---|
| Related Catalog | |
| References |
[1]. Ethambutol. Tuberculosis (Edinb), 2008. 88(2): p. 102-5. |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 345.3±22.0 °C at 760 mmHg |
| Melting Point | 199 - 204ºC |
| Molecular Formula | C10H24N2O2 |
| Molecular Weight | 204.310 |
| Flash Point | 113.7±12.9 °C |
| Exact Mass | 204.183777 |
| PSA | 64.52000 |
| LogP | -0.05 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.478 |
| Storage condition | 2-8℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2922191000 |
|---|
|
~%
74-55-5 |
| Literature: Journal of the American Chemical Society, , vol. 122, # 25 p. 5968 - 5976 |
|
~%
74-55-5 |
| Literature: Journal of the American Chemical Society, , vol. 122, # 25 p. 5968 - 5976 |
|
~78%
74-55-5 |
| Literature: Kotkar, Shriram P.; Sudalai, Arumugam Tetrahedron Asymmetry, 2006 , vol. 17, # 11 p. 1738 - 1742 |
|
~%
74-55-5 |
| Literature: Doklady Chemistry, , vol. 145, p. 597 - 600 Doklady Akademii Nauk SSSR, , vol. 145, p. 332 - 335 |
|
~%
74-55-5 |
| Literature: Justus Liebigs Annalen der Chemie, , p. 1455 - 1464 |
|
~%
74-55-5 |
| Literature: Justus Liebigs Annalen der Chemie, , p. 1455 - 1464 |
|
~%
74-55-5 |
| Literature: Tetrahedron, , vol. 58, # 49 p. 9765 - 9767 |
|
~%
74-55-5 |
| Literature: Journal of the American Chemical Society, , vol. 83, p. 2212 - 2213 |
|
~%
74-55-5 |
| Literature: Journal of Medicinal and Pharmaceutical Chemistry, , vol. 5, p. 835 - 845 |
| Precursor 9 | |
|---|---|
| DownStream 1 | |
| HS Code | 2922191000 |
|---|